Home

Latest News

12345678910
GO Q1 Earnings Call: Management Cites Execution Initiatives Amid Flat Same-Store Sales
Discount grocery store chain Grocery Outlet (NASDAQ:GO) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.5% year on year to $1.13 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.75 billion at the midpoint. Its non-GAAP profit of $0.13 per share was 87.6% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MRCY Q1 Earnings Call: Revenue Beat Expectations, Margins and Cash Flow Improve Amid Backlog Transition
Aerospace and defense company Mercury Systems (NASDAQ:MRCY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 1.5% year on year to $211.4 million. Its non-GAAP profit of $0.06 per share was $0.01 below analysts’ consensus estimates.
Via StockStory · May 19, 2025
WW Q4 Earnings Call: Product Integration, Subscriber Challenges, and Strategic Reset
Personal wellness company WeightWatchers (NASDAQ:WW) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 10.5% year on year to $184.4 million. Its non-GAAP profit of $0.32 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
Is the Market Bullish or Bearish on 3M?benzinga.com
Via Benzinga · May 19, 2025
The TLT Short Trade Is Crowdedtalkmarkets.com
Short positions in TLT, the popular 20-year US Treasury Bond ETF, have spiked to over 130 million shares, up from 107 million last month.
Via Talk Markets · May 19, 2025
VSTS Q1 Earnings Call: Revenue Miss, Service Challenges, and Leadership Transition Shape Outlook
Uniform rental provider Vestis Corporation (NYSE:VSTS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.7% year on year to $665.2 million. On the other hand, the company expects next quarter’s revenue to be around $678 million, close to analysts’ estimates. Its non-GAAP loss of $0.05 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
KLIC Q1 Earnings Call: Management Restructures Amid Revenue Miss and Macro Uncertainty
Semiconductor production equipment company Kulicke & Soffa (NASDAQ: KLIC) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $162 million. Next quarter’s revenue guidance of $145 million underwhelmed, coming in 0.5% below analysts’ estimates. Its non-GAAP loss of $0.52 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
WOW Q1 Earnings Call: Fiber Expansion and Margin Discipline Amid Revenue Pressure
Broadband and telecommunications services provider WideOpenWest (NYSE:WOW) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 7.1% year on year to $150 million. On the other hand, next quarter’s revenue guidance of $142.5 million was less impressive, coming in 0.7% below analysts’ estimates. Its GAAP loss of $0.17 per share was 11.3% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
1 Overlooked Potential Catalyst for Lucidfool.com
Via The Motley Fool · May 19, 2025
AGL Q1 Earnings Call: Membership Declines, Technology Investments, and Cautious Outlook for 2025
Healthcare services company Agilon Health (NYSE:AGL) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 4.5% year on year to $1.53 billion. The company expects next quarter’s revenue to be around $1.47 billion, close to analysts’ estimates. Its non-GAAP profit of $0.03 per share was $0.02 above analysts’ consensus estimates.
Via StockStory · May 19, 2025
UFPT Q1 Earnings Call: Medical Segment Growth and Strategic Expansion Drive Outperformance
Medical products company UFP Technologies (NASDAQ:UFPT) announced better-than-expected revenue in Q1 CY2025, with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of $2.47 per share was 22.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
America's Credit Strength Just Got Cut Again: Should You Panic?benzinga.com
Moody's cuts the U.S. credit rating to AA+, aligning with S&P and Fitch. Economists say markets remain unfazed, despite rising debt concerns.
Via Benzinga · May 19, 2025
Leading And Lagging Sectors For May 19, 2025benzinga.com
Via Benzinga · May 19, 2025
Options Reflecting Heightened Optimism, Although Not Dangerously So Quite Yettalkmarkets.com
The rally since early-April lows has equity bulls aggressively expressing their sentiment in options, which, should the current trajectory persist, will have potentially reached a dangerous level soon.
Via Talk Markets · May 19, 2025
GLDD Q1 Earnings Call: Outperformance Driven by Project Execution and Backlog Expansion
Dredging and coastal protection company Great Lakes Dredge & Dock (NASDAQ:GLDD) announced better-than-expected revenue in Q1 CY2025, with sales up 22.3% year on year to $242.9 million. Its non-GAAP profit of $0.49 per share was 86.7% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
Boeing Aircraft Tyres Confiscated By Poland Over Suspected Russia-Bound Shipment Amid Sanctions: Reportbenzinga.com
Polish customs seized 5 tons of tires for Boeing aircraft due to transit through Russia, citing Western sanctions.
Via Benzinga · May 19, 2025
FSTR Q1 Earnings Call: Rail Weakness Drives Revenue Miss, Management Maintains Bullish Full-Year Outlook
Railway infrastructure company L.B. Foster (NASDAQ:FSTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 21.3% year on year to $97.79 million. On the other hand, the company’s full-year revenue guidance of $560 million at the midpoint came in 3% above analysts’ estimates. Its GAAP loss of $0.20 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovidstocktwits.com
Novavax CEO John C. Jacobs called the approval a “significant milestone” as the company seeks to make its protein-based COVID-19 vaccine commercially available.
Via Stocktwits · May 19, 2025
ARRY Q1 Earnings Call: Revenue Beats Expectations, Margin and Cash Flow Pressures Persist
Solar tracking systems manufacturer Array (NASDAQ:ARRY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 97.1% year on year to $302.4 million. The company’s full-year revenue guidance of $1.1 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP loss of $0.01 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 19, 2025
Super Micro Expands AI Server Line With Nvidia’s Blackwell Chips: Retail Bull Sees Long-Term Gainsstocktwits.com
Super Micro launched over 20 RTX PRO 6000 Blackwell-powered AI systems to support advanced workloads across data centers and decentralized environments and cut costs.
Via Stocktwits · May 19, 2025
IPGP Q1 Earnings Call: Tariff Headwinds, Product Diversification, and Bookings Momentum
Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 9.6% year on year to $227.8 million. On the other hand, next quarter’s revenue guidance of $225 million was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $0.34 per share was 56.3% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
Doximity: Strong Growth but What's Next?fool.com
Via The Motley Fool · May 19, 2025
JJSF Q1 Earnings Call: Theater Weakness, Cost Pressures Shape Results, Company Eyes Recovery
Snack food company J&J Snack Foods (NASDAQ:JJSF) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1% year on year to $356.1 million. Its non-GAAP profit of $0.35 per share was 48.3% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
Forecasting The Future: 11 Analyst Projections For PACCARbenzinga.com
Via Benzinga · May 19, 2025
Breaking Down Illinois Tool Works: 12 Analysts Share Their Viewsbenzinga.com
Via Benzinga · May 19, 2025
GBTG Q1 Earnings Call: Revenue Misses Expectations as Management Cuts Full-Year Guidance
B2B travel services company Global Business Travel (NYSE:GBTG) fell short of the market’s revenue expectations in Q1 CY2025 as sales only rose 1.8% year on year to $621 million. On the other hand, the company expects next quarter’s revenue to be around $625 million, close to analysts’ estimates. Its non-GAAP profit of $0.16 per share was 6.6% below analysts’ consensus estimates.
Via StockStory · May 19, 2025
What Analysts Are Saying About Parker Hannifin Stockbenzinga.com
Via Benzinga · May 19, 2025
8 Analysts Have This To Say About Advance Auto Partsbenzinga.com
Via Benzinga · May 19, 2025
Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings)benzinga.com
Via Benzinga · May 19, 2025
12 Analysts Have This To Say About Delta Air Linesbenzinga.com
Via Benzinga · May 19, 2025
Shake Shack, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 19, 2025
Here’s how to make sure your tires are ready for road trip season
(BPT) - Summer is nearly here, and travelers everywhere are dreaming of the journeys they'll take with friends and family. But there's one aspect of road trip planning that often goes overlooked, and ironically, it's the only part of the vehicle that touches the road: tires.
Via Brandpoint · May 19, 2025
How Is The Market Feeling About Monolithic Power Systems?benzinga.com
Via Benzinga · May 19, 2025
How Do Investors Really Feel About Morningstar?benzinga.com
Via Benzinga · May 19, 2025
LIND Q1 Earnings Call: Occupancy, Yield Growth, and Strategic Initiatives Drive Outperformance
Cruise and exploration company Lindblad Expeditions (NASDAQ:LIND) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 17% year on year to $179.7 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.
Via StockStory · May 19, 2025
2 Stocks Down 63% and 36% to Buy Right Nowfool.com
Via The Motley Fool · May 19, 2025
Ripple Crypto Price News Todaytalkmarkets.com
After completing the significant corrective wave (II) near the $1.88 level, XRP/USD initiated a new bullish Elliott wave cycle.
Via Talk Markets · May 19, 2025
ZTS Q1 Earnings Call: Guidance Raised as Platform Products Drive Momentum Amid Competitive Pressures
Animal health company Zoetis (NYSE:ZTS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.4% year on year to $2.22 billion. The company’s full-year revenue guidance of $9.5 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $1.48 per share was 5.8% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
Regeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D Effortsstocktwits.com
Upon closing of the deal, 23andMe will be operated as a wholly owned direct or indirect unit of Regeneron and will continue operations as a personal genomics service.
Via Stocktwits · May 19, 2025
Tesla Robotaxi Launches In A Few Weeks. These Are The Details From Morgan Stanley-Tesla Meeting.investors.com
Tesla stock is up 24% in May.
Via Investor's Business Daily · May 19, 2025
AMD Offloads ZT Systems’ Data Center Infra Manufacturing Business To Sanmina For $3B, Retains AI Design Teamstocktwits.com
The deal between AMD and Sanmina also includes a contingent payment of up to $450 million based on future performance.
Via Stocktwits · May 19, 2025
AHCO Q1 Earnings Call: Guidance Trimmed as Diabetes and Sleep Segments Face Mixed Recovery
Healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.8% year on year to $777.9 million. On the other hand, the company’s full-year revenue guidance of $3.25 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auctioninvestors.com
The acquirer says it will continue 23andMe's consumer genome testing services. It acquired a number of programs, including the biobank.
Via Investor's Business Daily · May 19, 2025
SEE Q1 Earnings Call: Tariffs, Transformation, and Segment Realignment Shape Outlook
Integrated packaging solutions provider Sealed Air Corporation (NYSE:SEE) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.3% year on year to $1.27 billion. The company expects the full year’s revenue to be around $5.3 billion, close to analysts’ estimates. Its non-GAAP profit of $0.81 per share was 20.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
MAR Q1 Earnings Call: Revenue Beats Expectations Amid Cautious U.S. Outlook and Growth in International Segments
Global hospitality company Marriott (NASDAQ:MAR) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 4.8% year on year to $6.26 billion. Its non-GAAP profit of $2.32 per share was 3.1% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
Jim Cramer Was 'Skeptical' Of Rocket Lab, Now Says 'It's Actually A Decent Story'benzinga.com
Via Benzinga · May 19, 2025
SHLS Q1 Earnings Call: Revenue Beat Expectations Amid Margin Pressure, Outlook Supported by Backlog
Solar energy systems company Shoals (NASDAQ:SHLS) announced better-than-expected revenue in Q1 CY2025, but sales fell by 11.5% year on year to $80.36 million. Guidance for next quarter’s revenue was better than expected at $105 million at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $0.03 per share was in line with analysts’ consensus estimates.
Via StockStory · May 19, 2025
NOVT Q1 Earnings Call: Resilient Performance Amid Trade Headwinds and Strategic Acquisition
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next quarter’s revenue guidance of $235 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.74 per share was 9.9% above analysts’ consensus estimates.
Via StockStory · May 19, 2025
LIFEMD INC (NASDAQ:LFMD) – A Strong Contender for Growth Investorschartmill.com
LIFEMD (NASDAQ:LFMD) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a stock to watch for momentum investors.
Via Chartmill · May 19, 2025
Ethereum Found The Support; Bulls Back?talkmarkets.com
Ethereum may have found the support, so we should be aware of a bullish reversal and bigger recovery from technical and Elliott wave perspective.
Via Talk Markets · May 19, 2025